A Combination of Approved Drugs Enhances the Delivery of Anti-Bacterial Medications to Treat Tuberculosis
These drugs (bevacizumab and losartan) alone and in combination with anti-microbial agents, promoted anti-bacterial host responses and improved health outcomes in lab models with tuberculosis.